|
|
|
Insider
Information: |
Scangos George A |
Relationship: |
Director |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
942,251 |
|
Indirect Shares
|
3,765,803 |
|
|
Direct
Value |
$30,457,340 |
|
|
Indirect Value
|
$5,320,395 |
|
|
Total
Shares |
4,708,054 |
|
|
Total
Value |
$35,777,735 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Exelixis Inc |
EXEL |
Director |
2020-05-18 |
714,717 |
2020-05-18 |
23,595 |
Premium* |
|
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2008-08-26 |
33,188 |
2004-03-31 |
0 |
Premium* |
|
Biogen Idec Inc |
BIIB |
Chief Executive Office... |
2016-07-21 |
54,779 |
2016-07-21 |
10,756 |
Premium* |
|
Agilent Technologies Inc |
A |
Director |
2024-05-29 |
18,578 |
2024-05-29 |
17,893 |
Premium* |
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-05-30 |
120,989 |
2024-05-30 |
3,713,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
379 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 12 of 16
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
EXEL |
Exelixis Inc |
President & CEO |
|
2007-01-08 |
4 |
AS |
$9.34 |
$23,587 |
D/D |
(2,500) |
1,363,631 |
0 |
- |
|
EXEL |
Exelixis Inc |
President & CEO |
|
2007-01-17 |
4 |
AS |
$9.97 |
$25,282 |
D/D |
(2,500) |
1,361,131 |
0 |
- |
|
EXEL |
Exelixis Inc |
President & CEO |
|
2007-01-26 |
4 |
AS |
$9.44 |
$23,809 |
D/D |
(2,500) |
1,358,631 |
0 |
- |
|
EXEL |
Exelixis Inc |
President & CEO |
|
2007-02-01 |
4 |
AS |
$9.90 |
$24,936 |
D/D |
(2,500) |
1,356,131 |
0 |
- |
|
EXEL |
Exelixis Inc |
President & CEO |
|
2007-02-08 |
4 |
AS |
$10.30 |
$26,056 |
D/D |
(2,500) |
1,353,631 |
0 |
- |
|
EXEL |
Exelixis Inc |
President & CEO |
|
2007-02-12 |
4 |
AS |
$10.87 |
$27,498 |
D/D |
(2,500) |
1,351,131 |
0 |
- |
|
EXEL |
Exelixis Inc |
President & CEO |
|
2007-02-21 |
4 |
AS |
$11.25 |
$28,289 |
D/D |
(2,500) |
1,348,631 |
0 |
- |
|
EXEL |
Exelixis Inc |
President & CEO |
|
2007-02-27 |
4 |
AS |
$9.85 |
$25,224 |
D/D |
(2,500) |
1,346,131 |
0 |
- |
|
EXEL |
Exelixis Inc |
President & CEO |
|
2008-10-30 |
4 |
B |
$3.20 |
$80,000 |
D/D |
25,000 |
1,174,415 |
2.81 |
- |
|
VIR |
Vir Biotechnology, Inc. |
President and CEO |
|
2020-04-14 |
4 |
D |
$29.56 |
$6,999,985 |
I/I |
(236,806) |
1,907,329 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
President and CEO |
|
2020-04-14 |
4 |
A |
$29.56 |
$6,999,985 |
D/D |
236,806 |
4,713,559 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
President and CEO |
|
2021-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
111,000 |
4,609,559 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
President and CEO |
|
2022-02-17 |
4 |
AS |
$31.93 |
$320,074 |
D/D |
(10,024) |
130,715 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
President and CEO |
|
2022-02-18 |
4 |
AS |
$30.65 |
$543,304 |
D/D |
(17,726) |
112,989 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
President and CEO |
|
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
111,000 |
223,989 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
President and CEO |
|
2022-12-21 |
4 |
A |
$0.00 |
$0 |
I/I |
99,968 |
111,644 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
President and CEO |
|
2022-12-21 |
4 |
AS |
$0.00 |
$0 |
I/I |
(99,968) |
827,151 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
President and CEO |
|
2023-01-18 |
4 |
A |
$0.00 |
$0 |
I/I |
64,930 |
179,930 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
President and CEO |
|
2023-01-18 |
4 |
AS |
$0.00 |
$0 |
I/I |
(64,930) |
3,533,629 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
President and CEO |
|
2023-02-17 |
4 |
AS |
$25.29 |
$250,199 |
D/D |
(9,894) |
214,095 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
President and CEO |
|
2023-02-21 |
4 |
AS |
$28.02 |
$505,318 |
D/D |
(17,856) |
196,239 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
President and CEO |
|
2023-02-23 |
4 |
AS |
$25.97 |
$328,065 |
D/D |
(12,631) |
183,608 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
President and CEO |
|
2023-02-24 |
4 |
AS |
$22.74 |
$352,682 |
D/D |
(15,119) |
168,489 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
President and CEOOfficer |
|
2019-10-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,222,222 |
|
- |
|
VIR |
Vir Biotechnology, Inc. |
President and CEOOfficer |
|
2019-10-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,398,666 |
|
- |
|
379 Records found
|
|
Page 12 of 16 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|